Lamivudine Completed Phase N/A Trials for Hepatitis C Viral Infection / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00100581Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults
NCT00255840Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities
NCT000021083TC (Lamivudine; GR109714X) Open-Label Program
NCT00002217A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs
NCT00002216A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment
NCT00002155A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC
NCT00002369A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002430A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002411A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00001119Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
NCT00001075The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients
NCT00002407A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002401A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00002400A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00000896A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
NCT00000923Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328
NCT00000919A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
NCT00000922A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
NCT00080522Strategies for Delivering Anti-HIV Therapy in South Africa
NCT00087945Blood Levels of Abacavir in HIV Infected Adolescents
NCT00100646Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
NCT00100568Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal
NCT00100594Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China
NCT00034086Study of Anti-HIV Therapy Intensification
NCT00006443Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection
NCT00006617Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
NCT00014937Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
NCT00006441Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
NCT00002203A Study of Two Anti-HIV Drug Combinations
NCT00002168A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
NCT00004855Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs